US Broker Ratings

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Strong Revenue Growth and Promising Upside Potential

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $51.65 billion, IDEXX has..

Gilead Sciences (GILD) Stock Analysis: Uncovering a Potential 8.71% Upside with Robust Financials

Gilead Sciences, Inc. (NASDAQ: GILD) continues to be a significant player in the healthcare sector, particularly within the drug manufacturing industry. With a market capitalization of $142.41 billion, this biopharmaceutical..

The Cigna Group (CI) Stock Analysis: Exploring a 20.87% Potential Upside for Investors

The Cigna Group (NYSE: CI) presents a compelling case for investors seeking opportunities in the healthcare sector. With a robust market capitalization of $81.24 billion, this healthcare plans giant is..

Agilent Technologies (A) Stock Analysis: Exploring a 13.10% Potential Upside for Investors

Agilent Technologies, Inc. (NYSE: A) stands as a prominent player in the Healthcare sector, focusing on diagnostics and research. With a robust market capitalization of $34.55 billion, Agilent operates within..

BioNTech SE (BNTX) Stock Analysis: Promising 24.25% Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX), the German biotechnology powerhouse, has been at the forefront of innovation with its development of immunotherapies targeting cancer and infectious diseases. With a market capitalization of..

Cardinal Health, Inc. (CAH) Stock Analysis: Strong Buy Consensus and 21.85% Upside Potential

Cardinal Health, Inc. (NYSE: CAH), a prominent player in the healthcare sector, operates within the medical distribution industry. With a market capitalization of $35.37 billion, the company has established itself..

UnitedHealth Group (UNH) Stock Analysis: Exploring a Robust 6.96% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, offers a compelling proposition for investors seeking a blend of stability and growth. With a commanding market cap of..

Sanofi (SNY) Stock Analysis: Unveiling a 21% Potential Upside Amidst Market Challenges

Sanofi (SNY), a global powerhouse in the healthcare sector, is drawing significant attention from investors as it navigates a complex landscape with a potential 21.06% upside, according to analyst ratings...

AstraZeneca PLC (AZN) Stock Analysis: Riding the 6.96% Upside Potential with Strong Buy Ratings

AstraZeneca PLC (NASDAQ: AZN), a powerhouse in the healthcare sector and a leading player in the drug manufacturing industry, stands out with its impressive market capitalization of $251.5 billion. Headquartered..

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a Solid 10.48% Potential Upside

For investors eyeing the healthcare sector, Thermo Fisher Scientific Inc (NYSE: TMO) stands as a formidable player with a market capitalization of $188.8 billion. As a leader in diagnostics and..

Becton, Dickinson (BDX) Stock Analysis: Navigating Growth and Stability with a 4.18% Upside Potential

Becton, Dickinson and Company (NYSE: BDX) stands as a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $57.23 billion,..

Pfizer, Inc. (PFE) Stock Analysis: An 11% Upside Potential Amid Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) is a healthcare titan that has been making waves in the drug manufacturing sector. With a market capitalization of $147.14 billion, the company is a prominent..

Eli Lilly and Company (LLY) Investor Outlook: Navigating a 24.72% Upside Potential

Eli Lilly and Company (NYSE: LLY), a titan in the healthcare sector, continues to capture investor attention with its robust portfolio of pharmaceuticals and promising growth metrics. With a market..

Novo Nordisk A/S (NVO) Investor Outlook: Navigating Strong Growth and Potential Upside in Healthcare

Novo Nordisk A/S (NYSE: NVO), a titan in the healthcare sector, has been a focal point for investors seeking robust growth opportunities in the pharmaceutical industry. Headquartered in Bagsvaerd, Denmark,..

Abbott Laboratories (ABT) Stock Analysis: Evaluating a Healthcare Giant’s 7.46% Potential Upside

Abbott Laboratories (NYSE: ABT), a titan in the healthcare sector, continues to capture investor interest with its robust product portfolio and promising market performance. With a market capitalization of $230.77..

Boston Scientific (BSX) Stock Analysis: Strong Buy Ratings and a Promising 16.93% Upside Potential

Boston Scientific Corporation (NYSE: BSX), a leader in the medical devices sector, continues to capture investor attention with a compelling market presence and robust growth metrics. With a market capitalization..

MeiraGTx Holdings plc (MGTX) Stock Analysis: A 248% Potential Upside with Promising Gene Therapy Innovations

In the bustling world of biotechnology, MeiraGTx Holdings plc (NASDAQ: MGTX) is carving out a niche with its cutting-edge gene therapy solutions. With a market cap of $631.51 million, this..

Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Navigating a Challenging Market with 36.94% Potential Upside

Cross Country Healthcare, Inc. (NASDAQ: CCRN) stands as a prominent player in the healthcare sector, specifically within the medical care facilities industry. Headquartered in Boca Raton, Florida, the company specializes..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Exploring a 26.50% Potential Upside Amidst Healthcare Diagnostics Growth

Investors with a keen eye on the healthcare sector might find Myriad Genetics, Inc. (NASDAQ: MYGN) an intriguing prospect. Known for its innovative footprint in molecular diagnostics, Myriad Genetics is..

Emergent BioSolutions Inc. (EBS) Stock Analysis: Exploring the 44.85% Potential Upside for Investors

Emergent BioSolutions Inc. (NYSE: EBS), a key player in the healthcare sector specializing in preparedness and response solutions for public health threats, presents a compelling opportunity for investors with a..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds